Transcriptomics

Dataset Information

47

Genomic predictors of response to doxorubicin versus docetaxel in breast cancer


ABSTRACT: Low topo2a expression and ER-negative status were predictors of response to doxorubicin, while small tumor size and ER-negative status predicted response to docetaxel. Docetaxel was superior to doxorubicin in triple-negative/basal-like tumors, while no significant differences between these drugs were seen in the remaining intrinsic subtypes Keywords: reference x sample reference x sample

ORGANISM(S): Homo sapiens  

SUBMITTER: Charles Perou  Charles M Perou   M M Martin    

PROVIDER: E-GEOD-21997 | ArrayExpress | 2014-05-02

SECONDARY ACCESSION(S): GSE21997PRJNA127219

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets

2014-05-01 | E-GEOD-22358 | ArrayExpress
2014-05-02 | E-GEOD-11429 | ArrayExpress
2014-05-03 | E-GEOD-16113 | ArrayExpress
2014-05-03 | E-GEOD-15948 | ArrayExpress
2014-05-02 | E-GEOD-8516 | ArrayExpress
2014-05-02 | E-GEOD-22226 | ArrayExpress
2014-05-02 | E-GEOD-23428 | ArrayExpress
2014-08-22 | E-GEOD-51783 | ArrayExpress
2014-05-02 | E-GEOD-9343 | ArrayExpress
2014-05-04 | E-GEOD-34412 | ArrayExpress